BIN1 and Schnyder corneal dystrophy: Then we found that SCD participants, especially the SCD participants with obvious Aβ-related pathologic changes, had lower methylation levels of BIN1 promoter compared with controls, which indicated that hypomethylation of BIN1 promoter might increase the risk of preclinical AD.